After Hours
$
188.60
Change
-0.65 -0.34%
Volume
Volume 98,104
Apr 16, 2021, 7:59 p.m.
Quotes are delayed by 20 min
Previous close
$ 185.92
$ 189.25
Change
+3.33 +1.79%
Day low
Day high
$186.88
$190.30

52 week low
52 week high
$129.21
$218.00

Market cap
$178.19B
Average volume
3.50M
P/E ratio
27.86
Rev. per Employee
$701,137
EPS
6.79
Dividend
0.85
Div yield
1.80%
Ex dividend date
2/11/21
MarketWatch News on LLY
-
Lilly expects combination to be better in dealing with COVID variants than bamlanivimab alone
- Ciara Linnane
-
Lilly is seeking an EUA for bamlanivimab and etesevimab together as US COVID treatment
- Ciara Linnane
-
Eli Lilly requests revocation of emergency use authorization for bamlanivimab alone as COVID treatment
- Ciara Linnane
-
Lilly and Incyte say trial data showed 38% reduction in mortality by Day 28 for baricitinib plus SOC
- Ciara Linnane
-
Eli Lilly and Incyte say results of Phase 3 study of baricitinib in hospitalized COVID-19 patients failed to meet main goal
- Ciara Linnane
-
Pfizer's Xeljanz Faces Canadian Review Amid More Scrutiny of JAK Inhibitors
- Josh Nathan-Kazis
-
Lilly, Vir and Glaxo say combined monoclonal antibodies found 70% reduction in high viral load at day 7
- Ciara Linnane
-
Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment
- Ciara Linnane
-
GSK and Vir Submit Covid-19 Drug for FDA Authorization
- Josh Nathan-Kazis
-
FDA Advisory Panel Says Risks Outweigh Benefits of Pfizer and Lilly's Pain Drug
- Josh Nathan-Kazis
- Loading more headlines...
Analyst Ratings
-
Analysts Raise Ratings on Teva Stock on Ajovy’s FDA Approval
- MarketRealist.com
-
Analyst Recommendations for Teva Pharmaceutical in July
- MarketRealist.com
-
Analysts See a 9.5% Upside for SNY Stock over the Next Year
- MarketRealist.com
Other News on LLY
-
1 Cancer Stock to Buy and Hold for the Next Decade
- Motley Fool
-
Lilly Ends U.S. Use of Single Covid-19 Antibody Drug Alone
- Peter Loftus
-
Merck hurt by another setback in its battle against COVID-19
- Seeking Alpha
-
Merck Halts Covid-19 Treatment Trial for Hospitalized Patients
- Jared S. Hopkins
-
Drugmakers Are Vying for a Multibillion-Dollar Market
- Motley Fool
-
Should AbbVie Be Worried About Rinvoq?
- Motley Fool
-
March Mailbag: Invest Like a Girl
- Motley Fool
-
A Short Delay Is Still Bad News for AbbVie
- Motley Fool
-
Wall Street Breakfast: Inflation Sticker Shock
- Seeking Alpha
- Loading more headlines...
Press Releases on LLY
-
Drug Discovery Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2028
- Market Insight Reports
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com